Apollomics (APLM) COO Chen Yi-Kuei reports RSUs, shares and warrants on Form 3
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Apollomics Inc. director and COO Chen Yi-Kuei filed an initial Form 3 reporting his equity holdings. He directly holds restricted stock units covering 20,000 Class A Ordinary Shares, vesting in four installments of 5,000 shares each during 2026. Each unit represents the right to receive one share. Through Maxpro Investment Co., Ltd., he is attributed 101,248 Class A Ordinary Shares and warrants exercisable for 3,823 Class A Ordinary Shares at an adjusted exercise price of $1,150.00 per full share, or $11.50 per warrant. He disclaims beneficial ownership of the Maxpro-held securities except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Chen Yi-Kuei
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Warrants | -- | -- | -- |
| holding | Class A Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 20,000 shares (Direct);
Warrants — 3,823 shares (Indirect, By Maxpro Investment Co., Ltd.);
Class A Ordinary Shares — 101,248 shares (Indirect, By Maxpro Investment Co., Ltd.)
Footnotes (1)
- The reporting person is member of the Board of Directors of Maxpro Investment Co., Ltd. and is co-founder and managing director of Maxpro Ventures Ltd. The reporting person disclaims beneficial ownership of theses securities except to the extent of his pecuniary interest therein. The restricted stock units were vested with respect to 5,000 shares on February 17, 2026, with an additional 5,000 shares vesting on each of May 17, 2026, August 17, 2026 and November 17, 2026. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share. Reflects the adjusted exercise price of $1,150.00 per full share, as each warrant is exercisable for 0.01 Class A Ordinary Share at a price of $11.50 per warrant.
FAQ
What does Apollomics (APLM) COO Chen Yi-Kuei report on this Form 3?
Chen Yi-Kuei reports his initial beneficial ownership in Apollomics securities. The filing lists direct restricted stock units for 20,000 Class A Ordinary Shares and indirect holdings of shares and warrants through Maxpro Investment Co., Ltd., establishing his starting equity position as a director and COO.
How many Apollomics (APLM) RSUs does Chen Yi-Kuei hold and how do they vest?
He holds restricted stock units covering 20,000 Class A Ordinary Shares. These units vest as to 5,000 shares on February 17, 2026, with additional 5,000-share tranches vesting on May 17, 2026, August 17, 2026, and November 17, 2026, subject to standard RSU conditions.
What are the terms of the Apollomics (APLM) warrants held indirectly via Maxpro?
Maxpro holds warrants exercisable for 3,823 Class A Ordinary Shares of Apollomics. Each warrant is exercisable for 0.01 share at a price of $11.50 per warrant, which reflects an adjusted exercise price of $1,150.00 per full share, with expiration on March 29, 2028.
Does this Apollomics (APLM) Form 3 show insider buying or selling by Chen Yi-Kuei?
The Form 3 does not report any new purchases or sales of Apollomics securities. It functions as an initial statement of beneficial ownership, listing Chen Yi-Kuei’s existing RSUs, indirect shareholdings, and warrants positions as of the reporting date without recording market transactions.